当前位置: 首页 >> 检索结果
共有 4324 条符合本次的查询结果, 用时 1.5849609 秒

3941. Human Bone Marrow-derived Clonal Mesenchymal Stem Cells Decrease the Initial C-Reactive Protein Level in Patients With Moderately Severe to Severe Acute Pancreatitis.

作者: Il Sang Shin.;Chang-Hwan Park.;Jong Ho Moon.;Jun Kyu Lee.;Min Jae Yang.;Don Haeng Lee.; .
来源: Gastroenterology. 2023年164卷7期1317-1320.e2页

3942. Dupilumab: The New Kid on the Block for Management of Eosinophilic Esophagitis.

作者: Rena Yadlapati.
来源: Gastroenterology. 2023年165卷1期302-303页

3943. Reply.

作者: Floris De Voogd.;Geert R D'Haens.;Krisztina B Gecse.
来源: Gastroenterology. 2023年164卷7期1347-1348页

3944. Metachronous Colorectal Cancer in Icelandic MSH6 and PMS2 Lynch Syndrome Carriers in 1955-2017: A Population-based Study.

作者: Arna Kristin Andresdottir.;Haukur Einarsson.;Hildur Jonsdottir.;Jon Gunnlaugur Jonasson.;Einar Stefan Bjornsson.;Sigurdis Haraldsdottir.
来源: Gastroenterology. 2023年164卷7期1314-1316.e1页

3945. Efficacy and Safety of Drugs for Gastroparesis: Dopamine Receptor Antagonists Should Not Be Considered as a Single Pharmacologic Entity.

作者: Gareth J Sanger.;Paul L R Andrews.
来源: Gastroenterology. 2023年165卷2期520-521页

3946. A descriptive study of abdominal complications in patients with mild COVID-19 presenting to the emergency department: a single-center experience in Japan during the omicron variant phase.

作者: Shuhei Maruyama.;Daiki Wada.;Takahiro Oishi.;Fukuki Saito.;Kazuhisa Yoshiya.;Yasushi Nakamori.;Yasuyuki Kuwagata.
来源: BMC Gastroenterol. 2023年23卷1期43页
COVID-19 is widely known to induce a variety of extrapulmonary manifestations. Gastrointestinal symptoms have been identified as the most common extra-pulmonary manifestations of COVID-19, with an incidence reported to range from 3 to 61%. Although previous reports have addressed abdominal complications with COVID-19, these have not been adequately elucidated for the omicron variant. The aim of our study was to clarify the diagnosis of concomitant abdominal diseases in patients with mild COVID-19 who presented to hospital with abdominal symptoms during the sixth and seventh waves of the pandemic of the omicron variant in Japan.

3947. Comparison of therapeutic efficacy and treatment costs of self-expandable metal stents and plastic stents for management of malignant biliary obstruction.

作者: Renáta Bor.;Anna Fábián.;Mónika Szűcs.;Anita Bálint.;Mariann Rutka.;Tibor Tóth.;László Czakó.;Klaudia Farkas.;Norbert Buzás.;Ágnes Milassin.;Tamás Molnár.;Zoltán Szepes.
来源: BMC Gastroenterol. 2023年23卷1期41页
According to the European Society of Gastrointestinal Endoscopy guidelines, self-expandable metal stents (SEMSs) are preferable to plastic stents (PSs) in the management of pancreatic cancer, regardless of cancer stage. The aim of this study was to compare the therapeutic efficacy and treatment costs of SEMS and PS in the management of malignant biliary obstruction.

3948. Nomogram for predicting the overall survival of underweight patients with colorectal cancer: a clinical study.

作者: Jun Woo Bong.;Younghyun Na.;Yeonuk Ju.;Chinock Cheong.;Sanghee Kang.;Sun Il Lee.;Byung Wook Min.
来源: BMC Gastroenterol. 2023年23卷1期39页
An underweight individual is defined as one whose Body Mass Index (BMI) is < 18.5 kg/m2. Currently, the prognosis in patients with colorectal cancer (CRC) who are also underweight is unclear.

3949. Hepatitis C micro-elimination through the retrieval strategy of patients lost to follow-up.

作者: Cheng-Jen Chen.;Yung-Hsin Huang.;Chao-Wei Hsu.;Yi-Cheng Chen.;Ming-Ling Chang.;Chun-Yen Lin.;Yi-Hsien Shen.;Rong-Nan Chien.
来源: BMC Gastroenterol. 2023年23卷1期40页
World Health Organization sets up an ambitious and attainable goal to eliminate hepatitis C (HCV) by 2030. The previous diagnosed HCV patients lost to follow-up were considered as an important target group for HCV elimination. We conducted a call back program to retrieve the lost to follow-up HCV patients and link them to care in our hospital. By analyzing and comparing our result with that from other studies, we wish to improve our retrieval strategy and provide our experience to the general communities.

3950. AGA Clinical Practice Update on Telemedicine in Gastroenterology: Commentary.

作者: Ziad F Gellad.;Sarah Diamond.;Seth D Crockett.;Raymond K Cross.
来源: Gastroenterology. 2023年164卷4期690-695页
The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update (CPU) is to review the available evidence and provide expert advice regarding best practices for use of telemedicine in gastroenterology and hepatology.

3951. Looking for a Needle in a Haystack.

作者: Anna Cecilia Amaral.;Waleed K Hussain.;Samuel Han.
来源: Gastroenterology. 2023年164卷7期1066-1068页

3952. Increasing Pancreatic Cancer Incidence in Young Women in the United States: A Population-Based Time-Trend Analysis, 2001-2018.

作者: Yazan Abboud.;Jamil S Samaan.;Janice Oh.;Yi Jiang.;Navkiran Randhawa.;Daniel Lew.;Jenan Ghaith.;Pranav Pala.;ChristineAnn Leyson.;Rabindra Watson.;Quin Liu.;Kenneth Park.;Shirley Paski.;Arsen Osipov.;Brent K Larson.;Andrew Hendifar.;Katelyn Atkins.;Nicholas N Nissen.;Debiao Li.;Stephen J Pandol.;Simon K Lo.;Srinivas Gaddam.
来源: Gastroenterology. 2023年164卷6期978-989.e6页
Previous studies have shown an increasing incidence of pancreatic cancer (PC), especially in younger women; however, this has not been externally validated. In addition, there are limited data about contributing factors to this trend. We report age and sex-specific time-trend analysis of PC age-adjusted incidence rates (aIRs) using the National Program of Cancer Registries database without Surveillance Epidemiology and End Results data.

3953. Genetically Engineered Mouse Models Shine New Light on Decades-old Story of Trypsin in Pancreatitis.

作者: Bomi Lee.;Sohail Z Husain.;Ilya Gukovsky.
来源: Gastroenterology. 2023年164卷4期524-526页

3954. American Gastroenterological Association Membership Policy Priorities: Building the American Gastroenterological Association Advocacy Agenda.

作者: Amit Patel.;Brian C Jacobson.;Lisa Mathew.;Kathleen Teixeira.;Sarah Ankney.;Rotonya Carr.; .
来源: Gastroenterology. 2023年164卷6期847-850页

3955. Obeying the Law: Energy Balance in Alternate-Day Fasting, Exercise, or Both Together in Patients With Obesity and NAFLD.

作者: Brian Debosch.
来源: Gastroenterology. 2023年165卷1期301页

3956. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.

作者: Jinghan Wang.;Hongming Yu.;Wei Dong.;Cheng Zhang.;Mingtai Hu.;Wencong Ma.;Xiaoqing Jiang.;Hengyu Li.;Pinghua Yang.;Daimin Xiang.
来源: Gastroenterology. 2023年164卷6期990-1005页
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide, but there is a deficiency of early diagnosis biomarkers and therapeutic targets. Drug resistance accounts for most HCC-related deaths, yet the mechanisms underlying drug resistance remain poorly understood.

3957. TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype.

作者: Rossella Tricarico.;Jozef Madzo.;Gabrielle Scher.;Maya Cohen.;Jaroslav Jelinek.;Shinji Maegawa.;Rajeswari Nagarathinam.;Carly Scher.;Wen-Chi Chang.;Emmanuelle Nicolas.;Michael Slifker.;Yan Zhou.;Karthik Devarajan.;Kathy Q Cai.;Tim Kwok.;Pamela Nakajima.;Jinfei Xu.;Pietro Mancuso.;Valentina Doneddu.;Luigi Bagella.;Riley Williams.;Siddharth Balachandran.;Nicholas Maskalenko.;Kerry Campbell.;Xueying Ma.;Israel Cañadas.;Julen Viana-Errasti.;Victor Moreno.;Laura Valle.;Sergei Grivennikov.;Iuliia Peshkova.;Natalia Kurilenko.;Aleksandra Mazitova.;Ekaterina Koltsova.;Hayan Lee.;Martin Walsh.;Reuben Duttweiler.;Johnathan R Whetstine.;Timothy J Yen.;Jean-Pierre Issa.;Alfonso Bellacosa.
来源: Gastroenterology. 2023年164卷6期921-936.e1页
Aberrant DNA methylation is frequent in colorectal cancer (CRC), but underlying mechanisms and pathologic consequences are poorly understood.

3958. Chronic atrophic gastritis in different ages in South China: a 10-year retrospective analysis.

作者: Zefeng Zhang.;Xiaoguang Zhang.
来源: BMC Gastroenterol. 2023年23卷1期37页
To explore the prevalence, characteristics, age distribution and etiology changes of chronic atrophic gastritis (CAG) in South China.

3959. Correction: Assessing clinical trial failure risk factors and reasons in gastric cancer.

作者: Zikai Zhang.;Junyi Yin.;Yang Yue.;Yang Su.;Hong Jiang.
来源: BMC Gastroenterol. 2023年23卷1期38页

3960. PNPLA3 Genotype and Diabetes Identify Patients With Nonalcoholic Fatty Liver Disease at High Risk of Incident Cirrhosis.

作者: Vincent L Chen.;Antonino Oliveri.;Matthew J Miller.;Karn Wijarnpreecha.;Xiaomeng Du.;Yanhua Chen.;Kelly C Cushing.;Anna S Lok.;Elizabeth K Speliotes.
来源: Gastroenterology. 2023年164卷6期966-977.e17页
Non-alcoholic fatty liver disease (NAFLD) can progress to cirrhosis and hepatic decompensation, but whether genetic variants influence the rate of progression to cirrhosis or are useful in risk stratification among patients with NAFLD is uncertain.
共有 4324 条符合本次的查询结果, 用时 1.5849609 秒